Anti-MARK4 monoclonal antibody

Pre-made anti-MARK4 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to MARK4/MARK4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1150-Ab-1/ GM-Tg-hg-IP1150-Ab-2Anti-Human MARK4 monoclonal antibodyHuman
GM-Tg-rg-IP1150-Ab-1/ GM-Tg-rg-IP1150-Ab-2Anti-Rat MARK4 monoclonal antibodyRat
GM-Tg-mg-IP1150-Ab-1/ GM-Tg-mg-IP1150-Ab-2Anti-Mouse MARK4 monoclonal antibodyMouse
GM-Tg-cynog-IP1150-Ab-1/ GM-Tg-cynog-IP1150-Ab-2Anti-Cynomolgus/ Rhesus macaque MARK4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1150-Ab-1/ GM-Tg-felg-IP1150-Ab-2Anti-Feline MARK4 monoclonal antibodyFeline
GM-Tg-cang-IP1150-Ab-1/ GM-Tg-cang-IP1150-Ab-2Anti-Canine MARK4 monoclonal antibodyCanine
GM-Tg-bovg-IP1150-Ab-1/ GM-Tg-bovg-IP1150-Ab-2Anti-Bovine MARK4 monoclonal antibodyBovine
GM-Tg-equg-IP1150-Ab-1/ GM-Tg-equg-IP1150-Ab-2Anti-Equine MARK4 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1150-Ab-1/ GM-Tg-hg-IP1150-Ab-2; GM-Tg-rg-IP1150-Ab-1/ GM-Tg-rg-IP1150-Ab-2;
GM-Tg-mg-IP1150-Ab-1/ GM-Tg-mg-IP1150-Ab-2; GM-Tg-cynog-IP1150-Ab-1/ GM-Tg-cynog-IP1150-Ab-2;
GM-Tg-felg-IP1150-Ab-1/ GM-Tg-felg-IP1150-Ab-2; GM-Tg-cang-IP1150-Ab-1/ GM-Tg-cang-IP1150-Ab-2;
GM-Tg-bovg-IP1150-Ab-1/ GM-Tg-bovg-IP1150-Ab-2; GM-Tg-equg-IP1150-Ab-1/ GM-Tg-equg-IP1150-Ab-2
Products NameAnti-MARK4 monoclonal antibody
Formatmab
Target NameMARK4
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-MARK4 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1150-Ag-1Recombinant multi-species MARK4/ MARK4LS/ MARKL1 protein


    Target information

    Target IDGM-IP1150
    Target NameMARK4
    Gene ID57787,232944,680407,715346,484449,101084500,525675,100070770
    Gene Symbol and Synonyms2410090P21Rik,MARK4,MARK4L,MARK4S,MARKL1,MARKL1L,PAR-1D
    Uniprot AccessionQ96L34
    Uniprot Entry NameMARK4_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000007047
    Target ClassificationKinase

    The target: MARK4, gene name: MARK4, also named as MARK4LS, MARKL1, MARKL1L, PAR-1D, MARK4. This gene encodes a member of the microtubule affinity-regulating kinase family. These protein kinases phosphorylate microtubule-associated proteins and regulate the transition between stable and dynamic microtubules. The encoded protein is associated with the centrosome throughout mitosis and may be involved in cell cycle control. Expression of this gene is a potential marker for cancer, and the encoded protein may also play a role in Alzheimer's disease. Pseudogenes of this gene are located on both the short and long arm of chromosome 3. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.